학술논문

Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial
Document Type
Article
Source
In: BMJ Open Respiratory Research. (BMJ Open Respiratory Research, 17 July 2023, 10(1))
Subject
Language
English
ISSN
20524439